Perimeter Medical Imaging AI to Participate in Investor Webinar on February 6th
TORONTO and DALLAS, Jan. 30, 2025 // – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, today announced that Bristol Investor Relations will host an investor webcast Thursday, February 6, 2025 at 2:00 PM ET.
During the webcast, Adrian Mendes, CEO, Andrew Berkeley, CIO, and Sara Brien, CFO, will conduct a presentation that will cover key areas of Perimeter ‘s business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the live webcast and/or to ask questions during the live event, please pre-register at the following link:
https://us02web.zoom.us/webinar/register/WN_2VupRCLTS3GAlYyO1m6ToQ
An archived version of the webcast and presentation will be made available as soon as is practicable on the Company’s website under “News/Events” in the Investors Section.
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTC: PYNKF) is a company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that has recently been evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.
Perimeter Medical Imaging AI to Participate in Investor Webinar on February 6th, source.
Read the latest AI news at thinkaivolution.
